Horizon Therapeutics USA (Formerly Horizon Pharma)
Pharmaceutical Company
Based in CA
🤖
AI Overview
With $630K in lobbying spend across 21 quarterly filings, Horizon Therapeutics USA (Formerly Horizon Pharma) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2022.
$630K
Total Spend
5
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $150K |
| 2019 | $120K |
| 2020 | $120K |
| 2021 | $120K |
| 2022 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •-Implementation of the Affordable Care Act of 2010 (P.L. 111-148)
- •-Implementation of the Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development
- •-Implementation of the 21st Century Cures Ac
- •-Implementation of the Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development
- •-Implementation of the 21st Century Cures Act (P.L. 114-255)
- •-Implementation of the FDA Reauthorization Act (P
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.